valve icon

Xemed

Valve Medical

A modular Transcatheter Aortic Valve Replacement (TAVR) implant with an ultra-low entry profile
Investigational device not available for sale

Vascular access site bleeding remains a concern with existing TAVR devices, and there is still an unmet need to address patients with challenging femoral access.

>72,000 /yr
TAVR procedures are
conducted in the USA1
>3000 /yr
TAVR patients that require alternative
access site 1
18%
In Asian population
<5.5mm diameter of the
Common Femoral
Artery - unmet need2
  1. STS-ACC TVT Registry of Transcatheter Aortic Valve Replacement, Journal of The American College of Cardiology, VOL. 76, NO. 21, 2020
  2. Iliofemoral anatomy among Asians: Implications for transcatheter aortic valve implantation, International Journal of Cardiology, 21 April 2012

Xemed
TAVR
Aortic Valve

Valve Medical's Xemed TAVR patented modular technology utilizes a standard 12F sheath to deliver the valve. We aim to reduce bleeding complications related to device profile and offer a solution to patient populations who require smaller devices than what is currently available.
structural heart 1

Xemed Valve Advantages

Ultra Low
Entry Profile

True 12F entry profile

Adaptive Sealing
Technology

Unique adaptive sealing technology designed to reduce paravalvular leakage

Optimized Leaflet
Design

3D leaflet design providing higher durability and superior hemodynamics

Short Frame

Short frame designed to minimize interference with the conduction system and facilitate coronary access
Prof. Eberhard Grube presenting the FIH implantation of the XEMED TAVR device at the TVT2023 Structural Heart Summit, Phoenix, AZ

Clinical Activity

First-in-Human (FIH) implantation of the Xemed Transcatheter Aortic Valve Replacement (TAVR) system in Israel, introducing a revolutionary advancement in Structural Heart procedures with the world's first modular valve. The distinguishing feature of the valve is its modular design, which has an ultra-low profile, enabling the use of a standard 12 Fr sheath. This reduction in size allows for universal access to trans-femoral delivery for patients, including those with challenging anatomies, while reducing the risk of vascular and bleeding complications, still common in TAVR procedures.
valve icon

About Valve Medical

Valve Medical, a member of the Medinol Group, was founded with the aim to reduce bleeding complications related to device profile and offer a solution to patient populations who require smaller devices than what is currently available.

We have assembled a talented team of biomedical, materials, chemical and mechanical engineers who share a common goal: to develop a dependable, high quality, and long-lasting medical device.
As a member of the Medinol Group, we benefit from the company’s in-house expertise in minimally invasive vascular procedures, which spans more than three decades. We pride ourselves on being innovative thinkers who can rapidly turn ideas into tangible products.

 

Team Members

Dr. Yoram Izhaki
CEO
Tom Ordan
VP R&D
Silvia Stolarski
QA/RA Leader
Aviad Achrak
R&D Group Manager
Shaily Shohat
Fluid Mechanics Laboratory Team Manager
contact icon

Contact Us


    Accessibility Toolbar